Get started
Work

In-vitro Activities of Zoliflodacin and Solithromycin Against Neisseria gonorrhoeae Isolates from Korea

Year: 2025
Type: article
Abstract: isolates, and zoliflodacin has shown non-inferiority to ceftriaxone/azithromycin dual therapy in a clinical phase 3 trial. Collectively, our findings highlight the potential of zoliflodacin as a novel therapeutic agent for gonococcal infections, particularly in the context of rising multidrug resistance, and highlight the need for continued surveillance and development of alternative antimicrobial strategies.
DOI: 10.3343/alm.2024.0522
Authors: Kyoung Ho Roh, Nguyen Dinh Luong, Changseung Liu, Young Hee Seo, Hyukmin Lee, Magnus Unemo, Kyungwon Lee
Institutions: National Health Insurance Service Ilsan Hospital, National Health Insurance Service, Institut Pasteur de Nha Trang, University of Ulsan, Gangneung Asan Hospital, Yonsei University, Örebro University
Language: English
Subfield: Microbiology
Open Access status: diamond
OpenAlex ID: W4409868779
FWCI: 3.695
Cites:
Cited by: 8
Related to: 10